Which of the following nursing interventions is most appropriate for a patient with Systemic Lupus Erythematosus (SLE) experiencing mild joint swelling and tenderness?

C) Educate the patient about the importance of sun avoidance to prevent rash exacerbation

A) Encourage bed rest to prevent further joint damage

B) Apply cold packs to affected joints to reduce inflammation

C) Educate the patient about the importance of sun avoidance to prevent rash exacerbation

D) Advise the patient to increase fluid intake to prevent dehydration

Which of the following nursing interventions is most appropriate for a patient with Systemic Lupus Erythematosus (SLE) experiencing joint pain and swelling?

C) Educate the patient on the importance of regular rest periods

A) Encourage high-impact exercises to improve joint mobility

B) Advise the patient to apply cold compresses to affected joints

C) Educate the patient on the importance of regular rest periods

D) Recommend a high-protein diet to reduce inflammation

What is the primary purpose of starting the patient on hydroxychloroquine therapy in the management of Systemic Lupus Erythematosus (SLE)?

B) To manage skin and joint symptoms

A) To reduce joint inflammation

B) To manage skin and joint symptoms

C) To treat gastrointestinal discomfort

A patient with systemic lupus erythematosus (SLE) is experiencing mild gastrointestinal discomfort after starting hydroxychloroquine. Which nursing intervention is most appropriate to help alleviate this side effect?

A) Administer hydroxychloroquine with meals

B) Increase the dose of hydroxychloroquine

C) Discontinue hydroxychloroquine immediately

D) Advise the patient to avoid all dairy products

A patient with SLE is experiencing mild gastrointestinal discomfort due to hydroxychloroquine. What is the most appropriate nursing intervention to help alleviate this side effect?

B) Suggest the patient take hydroxychloroquine with meals

A) Instruct the patient to take hydroxychloroquine on an empty stomach

B) Suggest the patient take hydroxychloroquine with meals

C) Advise the patient to increase their fluid intake

D) Encourage the patient to take an antacid before each dose

What is the primary reason for scheduling bi-weekly laboratory tests to monitor ALT and AST levels in a patient taking hydroxychloroquine?

B) To monitor for potential liver damage due to medication use

A) To assess the effectiveness of hydroxychloroquine in treating SLE

B) To monitor for potential liver damage due to medication use

C) To evaluate the patient's immune function

D) To check for electrolyte imbalances

What is the primary purpose of scheduling bi-weekly liver function tests for this patient?

A) To monitor for potential liver damage caused by hydroxychloroquine

B) To assess the patient's cardiovascular health

C) To evaluate the effectiveness of the patient's dietary adjustments

D) To track improvements in the patient's gastrointestinal symptoms

Which laboratory test result indicates an improvement in the patient's liver function following lifestyle modifications and medication adherence?

A) ALT levels decreasing from 52 U/L to 45 U/L

B) Hemoglobin stable at 13.5 g/dL

C) Creatinine level of 0.9 mg/dL

D) White blood cell count of 6,800 cells/mcL

Which laboratory finding in the patient's results indicates an improvement in liver function?

A) ALT levels decreasing from 52 U/L to 45 U/L

B) Creatinine level of 0.9 mg/dL

C) Hemoglobin stable at 13.5 g/dL

D) White blood cell count of 6,800 cells/mcL

SLE in acute setting - Nursing Case Study

Pathophysiology

• Primary mechanism: In Systemic Lupus Erythematosus (SLE), the immune system mistakenly targets the body's own cells, creating autoantibodies. These autoantibodies form immune complexes that deposit in tissues, causing inflammation and damage.

• Secondary mechanism: The complement system, part of the immune response, is activated by these immune complexes. This leads to further inflammation and tissue injury, especially affecting the skin, joints, kidneys, and blood vessels.

• Key complication: In the acute setting, this can result in lupus nephritis, where immune complexes damage the kidneys, leading to proteinuria, hematuria, and reduced kidney function. Prompt recognition and management are crucial to prevent further complications.

Patient Profile

Demographics:

29-year-old female, elementary school teacher

History:

• Key past medical history: Diagnosed with systemic lupus erythematosus (SLE) 2 years ago, mild flares managed with medication

• Current medications: Hydroxychloroquine 200 mg daily, ibuprofen 400 mg as needed for joint pain

• Allergies: No known drug allergies

Current Presentation:

• Chief complaint: Mild joint pain and fatigue

• Key symptoms: Low-grade fever, mild arthralgia in hands and knees, fatigue, mild facial rash

• Vital signs: Temperature 37.8°C (100°F), Heart rate 78 bpm, Blood pressure 118/72 mmHg, Respiratory rate 16 breaths per minute, Oxygen saturation 98% on room air

Section 1

Initial Assessment Findings:

Upon admission, the nursing team conducts a thorough assessment of the patient. The patient is alert and oriented, though she appears slightly fatigued. Her skin examination reveals a mild erythematous rash across the cheeks and bridge of the nose, indicative of a classic butterfly rash commonly seen in SLE. Joint examination notes mild swelling and tenderness in the metacarpophalangeal joints of both hands and knees, consistent with the patient's report of arthralgia. No deformities or significant range of motion limitations are observed, suggesting early-stage joint involvement.

Laboratory tests are ordered to further evaluate the patient's current status. Initial lab results show a slightly elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), indicating inflammation. Complete blood count reveals mild leukopenia, a common hematological manifestation of SLE, but hemoglobin and platelet levels are within normal limits. Urinalysis is performed to assess renal function, showing trace proteinuria, but no hematuria or significant abnormalities, suggesting that while there may be a mild renal involvement, it is not yet severe.

The nursing team prioritizes education and reassurance, emphasizing the importance of medication adherence and lifestyle modifications to manage symptoms and prevent exacerbations. The patient is encouraged to maintain regular follow-ups with her rheumatologist and report any new or worsening symptoms promptly. The focus remains on monitoring and managing her symptoms effectively to maintain her quality of life and prevent progression of the disease.

Section 2

Response to Interventions:

Following the initial assessment and establishment of the care plan, the nursing team implements interventions with a focus on symptom management and patient education. The patient is started on low-dose corticosteroids to help reduce inflammation and alleviate her arthralgia. Hydroxychloroquine is also initiated, given its efficacy in managing skin and joint symptoms of SLE. Over the next few days, nursing staff closely monitors the patient for any side effects of these medications, such as gastrointestinal discomfort or potential retinal toxicity from hydroxychloroquine, and provides supportive care as needed.

The patient reports a noticeable reduction in joint pain and swelling, indicating a positive response to the initiated medication regimen. Her fatigue also shows slight improvement, although the nursing team continues to encourage balanced rest and activity to help manage energy levels. Vital signs remain stable, with blood pressure at 118/76 mmHg, heart rate at 78 bpm, respiratory rate at 16 breaths per minute, and temperature at 98.6°F, suggesting no acute complications are arising from the treatment plan.

The patient is receptive to education sessions, where nurses reinforce the importance of sun protection to prevent exacerbation of her skin symptoms, as well as stress management techniques to minimize disease flares. The patient expresses understanding and commits to wearing sunscreen daily and attending her follow-up appointments. As discharge planning begins, the nursing team ensures that she has access to her medications and understands the need for regular monitoring of her condition, setting the stage for ongoing management of her SLE in the outpatient setting.

Section 3

Change in Patient Status:

As the patient continues her treatment regimen, the nursing team observes a slight shift in her status. While her joint pain and fatigue remain well-managed, she begins to experience mild gastrointestinal discomfort, characterized by occasional nausea and a slight decrease in appetite. This development prompts the nursing team to reassess her tolerance to the medications, particularly hydroxychloroquine, which is known to cause such side effects. The nursing staff promptly communicates these observations to the healthcare provider, who decides to adjust the timing of her medication intake and suggests taking it with meals to mitigate gastrointestinal distress.

Additionally, a routine laboratory workup reveals a minor elevation in liver enzymes, which is not uncommon with medication adjustments in SLE management. The results show an ALT level of 55 U/L and an AST level of 48 U/L, both slightly above the normal range, warranting continued monitoring but not immediate intervention. The nursing team educates the patient on recognizing symptoms of significant liver involvement, such as jaundice or dark urine, and reinforces the importance of reporting any new or worsening symptoms.

In light of these changes, the patient's care plan is updated to include dietary modifications to support gastrointestinal health and regular follow-up labs to monitor liver function. The patient remains committed to her treatment and understands the importance of adhering to the revised plan. Her vital signs remain stable, and she reports no new issues with her skin or other systemic symptoms. The nursing team continues to provide reassurance and support, ensuring that the patient feels confident in managing her condition while preparing for her transition to outpatient care.

Section 4

Response to Interventions:

Following the adjustment in the timing of her hydroxychloroquine intake and the incorporation of meals, the patient reports a noticeable improvement in her gastrointestinal symptoms. Her nausea has significantly decreased, and she is able to maintain a more consistent appetite, contributing positively to her overall energy levels. The nursing team conducts a follow-up assessment to review her vital signs, which remain stable: blood pressure is 118/76 mmHg, heart rate is 72 beats per minute, respiratory rate is 16 breaths per minute, and temperature is 98.4°F. These stable vital signs, alongside her improved gastrointestinal comfort, indicate a positive response to the intervention.

To ensure comprehensive care, the nursing team schedules a series of follow-up laboratory tests to monitor her liver function more closely. These tests will be conducted bi-weekly to track any trends or changes in her ALT and AST levels. The patient expresses understanding and concurs with the importance of these follow-up tests, recognizing the role they play in her ongoing health management. She is also encouraged to maintain a symptom diary, documenting any new or recurring issues, and continues to receive education on lifestyle modifications that could support her liver health, such as reducing dietary fats and alcohol intake.

The nursing team remains attentive, ready to address any new concerns that may arise and reinforce the importance of medication adherence and lifestyle adjustments. They provide the patient with resources for further information on SLE management and support systems available in the community. As the patient prepares for her transition to outpatient care, she feels more empowered and informed about managing her condition, confident in the plan established by her healthcare team.

Section 5

New Diagnostic Results:

Two weeks after the initial intervention adjustments, the patient returns for her scheduled follow-up appointment. The nursing team conducts a thorough review of the most recent laboratory results. The patient's liver function tests show a slight improvement, with ALT levels decreasing from 52 U/L to 45 U/L and AST levels from 48 U/L to 42 U/L, both trending towards the normal range. These results suggest that the lifestyle modifications and medication adherence are effectively contributing to better liver health. The patient expresses relief at these findings, feeling reassured that her efforts are yielding positive outcomes.

In addition to liver function tests, the team also reviews her complete blood count (CBC) and renal panel. The CBC shows stable hemoglobin at 13.5 g/dL and a normal white blood cell count of 6,800 cells/mcL, indicating no new hematological issues. Her renal panel is within normal limits, with a creatinine level of 0.9 mg/dL and a blood urea nitrogen (BUN) of 14 mg/dL, confirming that her kidney function remains uncompromised. These stable parameters further reinforce the positive response to her current treatment plan and provide a solid foundation for ongoing management.

Encouraged by the results, the nursing team continues to stress the importance of regular monitoring and adherence to the prescribed regimen. They engage the patient in a discussion about potential triggers of SLE flare-ups and strategies to avoid them, such as stress management and sun protection. The patient is scheduled for her next follow-up in another two weeks, with a continued focus on maintaining stability and preventing complications. This ongoing collaboration and monitoring set the stage for a proactive approach to managing her condition as she continues her journey with SLE.